Knowing more about chloroquine/hydroxycloroquine in COVID-19 patients.

Cassone, Antonio; Iacoviello, Licia; Cauda, Roberto

Cassone, Antonio; Iacoviello, Licia; Cauda, Roberto.

Cassone A; Polo d'Innovazione della Genomica, Genetica e Biologia, University of Siena.
Iacoviello L; Department of Epidemiology & Prevention, IRCCS Neuromed, Pozzilli (IS), Italy.
Cauda R; Department of Medicine & Surgery, University of Insubria, Varese, 21100, Italy.

Future Microbiol ; 15: 1523-1526, 2020 10.

Article in English | MEDLINE | ID: covidwho-976144

Subject(s)

Antiviral Agents/therapeutic use; COVID-19 Drug Treatment; Chloroquine/therapeutic use; Hydroxychloroquine/therapeutic use; Anti-Inflammatory Agents/therapeutic use; Humans; Immunomodulation; Randomized Controlled Trials as Topic

Keywords

COVID-19; HCQ dosage; SARS-CoV-2; anti-inflammatory; antiviral; hydroxychloroquine; immunomodulation; observational studies; randomized controlled trials

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Chloroquine / COVID-19 Drug Treatment / Hydroxychloroquine Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Future Microbiol Journal subject: Microbiology Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google